Oncology News

A patient with liver cancer at the University of Wisconsin Carbone Cancer Center recently received novel MRI-guided radiation therapy, marking the first time the institution has used the technology to treat cancer, according to a news release.

Can-Fite BioPharma received a Japanese patent for CF102, a drug under development to repair liver cells and function in patients with hepatocellular carcinoma, according to a news release.

WHO’s International Nonproprietary Name group has recommended the generic name mipsagargin for GenSpera’s G-202 in the treatment of hepatocellular carcinoma, according to a press release.

The first patient enrolled in the OPTIMA study for primary liver cancer will be studied at the Kyungpook National University Hospital in South Korea, according to a news release.

Patients with viral or alcohol-related cirrhosis awaiting liver transplantation and who underwent colonoscopy were at high risk for developing colorectal neoplasia, according to new study data.

Veterans with hepatocellular carcinoma related to nonalcoholic fatty liver disease underwent surveillance at a lower rate compared with veterans with hepatocellular carcinoma associated with hepatitis C virus or alcohol abuse, according to new study data.

Risk for hepatocellular carcinoma recurrence after liver transplantation was lower among patients who waited more than 120 days from exception to transplantation compared with patients who did not in a recent study.

High concentrations of biomarkers for inflammation and hyperinsulinemia were associated with a high risk for hepatocellular carcinoma and other cancers, according to recent study data.

Women with hepatocellular carcinoma demonstrated longer OS than men, according to results of a SEER analysis.

Higher BMI increased individuals’ risks for 10 common cancers, according to results of a population-based cohort study conducted in the United Kingdom.